Literature DB >> 34101006

Outpatient lower extremity fracture surgery: should we be concerned?

Charlotte N Shields1, Sara Solasz1, Leah J Gonzalez1, Yixuan Tong1, Sanjit R Konda2, Kenneth A Egol3,4.   

Abstract

PURPOSE: With rising healthcare costs and insurance push against non-emergent hospital admission, lower extremity fracture treatment is shifting toward outpatient procedures over inpatient hospitalizations. This study compares outcomes for fractures treated as inpatient versus outpatient.
METHODS: We conducted a retrospective review of lower extremity fracture patients. We collected demographics, injury information, hospital course, and complication data. Length of stay was categorized as "inpatient" and "outpatient" based a 24-h hospital stay cutoff. Data analysis included differences between cohorts with regards to readmissions and complications.
RESULTS: We identified 229 patients who met inclusion criteria. Inpatient versus outpatient status was predictive of in-hospital complications; however, inpatient versus outpatient status did not predict 1-year readmission.
CONCLUSION: Outpatient surgery is safe and effective. As the population increases and ages, low-risk surgeries should be considered for outpatient rather than inpatient stays to lower costs, save resources, and reduce complications.
© 2021. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.

Entities:  

Keywords:  Inpatient; Outpatient; ‘Hospital costs’; ‘Lower extremity, fractures’

Mesh:

Year:  2021        PMID: 34101006     DOI: 10.1007/s00590-021-03029-6

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  13 in total

1.  Outpatient surgery as a means of cost reduction in total hip arthroplasty: a case-control study.

Authors:  Michael Aynardi; Zachary Post; Alvin Ong; Fabio Orozco; Dean C Sukin
Journal:  HSS J       Date:  2014-07-12

2.  Economic Analysis and Patient Satisfaction Associated With Outpatient Total Ankle Arthroplasty.

Authors:  Tyler Gonzalez; Erica Fisk; Christopher Chiodo; Jeremy Smith; Eric M Bluman
Journal:  Foot Ankle Int       Date:  2017-01-06       Impact factor: 2.827

3.  Epidemiology of lower limb fractures in general practice in the United Kingdom.

Authors:  J A Kaye; H Jick
Journal:  Inj Prev       Date:  2004-12       Impact factor: 2.399

4.  Safe Selection of Outpatient Joint Arthroplasty Patients With Medical Risk Stratification: the "Outpatient Arthroplasty Risk Assessment Score".

Authors:  R Michael Meneghini; Mary Ziemba-Davis; Marshall K Ishmael; Alexander L Kuzma; Peter Caccavallo
Journal:  J Arthroplasty       Date:  2017-03-14       Impact factor: 4.757

5.  The burden of hospitalised fractures in Sweden.

Authors:  O Johnell; J A Kanis; B Jonsson; A Oden; H Johansson; C De Laet
Journal:  Osteoporos Int       Date:  2004-07-01       Impact factor: 4.507

6.  Cost savings of outpatient versus standard inpatient total knee arthroplasty.

Authors:  Adrian Huang; Jae-Jin Ryu; Geoffrey Dervin
Journal:  Can J Surg       Date:  2017-02       Impact factor: 2.089

7.  The Determinants of Costs and Length of Stay for Hip Fracture Patients.

Authors:  Adriana Castelli; Silvio Daidone; Rowena Jacobs; Panagiotis Kasteridis; Andrew David Street
Journal:  PLoS One       Date:  2015-07-23       Impact factor: 3.240

Review 8.  Hybrid fracture fixation systems developed for orthopaedic applications: A general review.

Authors:  Li Tian; Ning Tang; To Ngai; Chi Wu; Yechun Ruan; Le Huang; Ling Qin
Journal:  J Orthop Translat       Date:  2018-07-21       Impact factor: 5.191

9.  Epidemiology of low-energy lower extremity fracture in Chinese populations aged 50 years and above.

Authors:  Yanbin Zhu; Song Liu; Wei Chen; Bo Liu; Fei Zhang; Hongzhi Lv; Chenni Ji; Xiaolin Zhang; Yingze Zhang
Journal:  PLoS One       Date:  2019-01-14       Impact factor: 3.240

10.  An Online Charging Scheme for Wireless Rechargeable Sensor Networks Based on a Radical Basis Function.

Authors:  Jia Yang; Jian-Shuang Bai; Qiang Xu
Journal:  Sensors (Basel)       Date:  2019-12-30       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.